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ABSTRACT
Design and Evaluation of Oligonucleotide Microarrays for
the Detection of Bovine Pathogens
by
Ryan W. Black, Master of Science
Utah State University, 2009
Major Professor: Dr. Lee Rickords
Department: Animal, Dairy and Veterinary Sciences
Two microarray designs were developed and produced to screen for multiple
bovine pathogens commonly found in the cattle industry today. The first microarray was
designed, built, and processed in-house using conventional material and equipment and
targeted Pasteurella multocida, Manheimia haemolytica, Histophilus somni, and
Arcanobacterium pyogenes. For each pathogen, 12 perfect-match oligonucleotide
probes, which were also designed in-house, targeted different sections of the respective
16S ribosomal genes, and were coupled with 12 corresponding mismatched probes for
background. These arrays were able to produce distinct hybridization patterns for each
pathogen that were easily visible without the need for computer analysis. However, the
need for PCR amplification of the 16S gene prior to hybridization motivated us to explore
more efficient array options. The second designed microarray, a custom Affymetrix
GeneChip, targeted Escherichia coli, Salmonella typhimurium, and Salmonella dublin in
addition to the previously mentioned pathogens and was more successful in overall
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performance than the “in-house” arrays. In addition to the 16S gene, oligonucleotide
probes targeted other genes (from 2 to >4500, depending on whether the genome was
sequenced) that were unique to each pathogen. This array also differed from the “inhouse” arrays in that mismatched probes were not designed. The different probe sets
performed at different detection limits as P. multocida, A. pyogenes, S. typhimurium, and
S. dublin were detected with as little as 250ng of hybridized genomic DNA (gDNA),
while M. haemolytica, H. somni, and E. coli required as much as 1µg gDNA. These
pathogens were also spiked into bovine tissue to simulate multiorgan infections in which
they were individually detected with the microarray design.
(76 pages)
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CHAPTER I
LITERATURE REVIEW
Introduction
A variety of diagnostic techniques are available to both ranchers and veterinarians
for the identification of bovine pathogens. Observing clinical symptoms of a disease
such as fever, diarrhea, congestion, and upper respiratory symptoms is often sufficient in
making tentative diagnoses. Abnormal behavior, such as depression, lethargy, instability
or incoordination can also be the manifestations of various infections. Gross lesions such
as hemorrhage, infiltrates, abscesses, scar tissue, and excessive fluid in body cavities,
may also be discernible internally in affected animals.1,2,12,44,71
Diagnosis of disease using clinical observations requires experience and historical
knowledge of herds and individuals within a herd, since symptoms of various diseases
can be similar. However, definitive diagnostics are needed to confirm a clinical
diagnosis. Veterinary diagnostic laboratories focus on identifying pathogens that cause
disease using techniques that include bacterial culture, biochemical testing, serological
testing, and molecular diagnostic techniques. Microbiological testing allows a
veterinarian to identify specific bacteria based on colony characteristics, biochemical
profiles and staining characteristics. Serologic evaluation, Enzyme-Linked
ImmunoSorbent Assay (ELISA), serum neutralization (SN), and other techniques are also
used to identify specific antibodies or antigens found within the bloodstream or tissues to
confirm the presence of or recent exposure to particular pathogens.1 Additional target
factors include specific enzymes, microorganisms or certain components thereof, or
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particles that agglutinate when mixed with specific antiserums.48,65 Molecular
techniques, such as polymerase chain reaction (PCR), can identify pathogens by
amplification of genetic material of the agent, often targeting specific genes that are
unique to an organism. Researchers continue to make improvements on these techniques
with the goal of making the tests more accurate, more efficient, less complicated, and
most importantly (at least to ranchers), less expensive. A relatively new technology, the
microarray, used primarily for gene expression analysis of biological systems, is recently
and increasingly finding use as a detection tool for the identification of bacterial and viral
genomes within infected tissue and ecological environmental samples.40 In this report,
microarray technology is used to specifically identify pathogens associated with a
number of mixed infections that are common to the cattle industry.
Disadvantages of Current Techniques Used to Diagnose Bovine Diseases
The primary methods that veterinary diagnostic laboratories use to diagnose a
disease, other than clinical observations, include microbiology, biochemical tests,
serological tests, histopathology, and molecular diagnostic techniques. For many
diseases, isolation of the infection-causing pathogens is the most direct method of
confirming a diagnosis. Materials used for bacterial culture are cost-effective. However,
isolating a pathogen from a mixed culture can be difficult and very time consuming,
taking anywhere from days to months to cultivate sufficient colonies27 for definitive
diagnosis. Moreover, culture conditions are not known for every pathogen. Finally,
culturing zoonotic pathogens poses potential health risks to personnel and requires
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Biological Safety Level (BSL) facilities, proper equipment, training and protocols to
ensure the safety of those handling the pathogens.15
Biochemical and serological tests are designed to be more species and pathogen
specific and techniques will vary depending on the type of pathogens involved. The
application of specific techniques requires some level of foreknowledge as to the identity
of the suspected pathogen, since each test is species and pathogen specific. Individually,
these tests may be inexpensive, however, due to the method of testing (serum
neutralization assays),44 multiple tests could be required for confirmation of a disease
which would result in higher labor and material costs.
Molecular techniques, like PCR, have made great strides in providing a cost
efficient, fast, and safe means for diagnosing pathogens present in samples. However,
culture is still sometimes necessary, and many pathogens require different experimental
conditions and optimized protocols and reagents, which again requires some suspicion as
to the identity of the pathogen.
Microarrays, another molecular technique, provide a means of potentially creating
an all-in-one diagnostic assay which provides the ability to screen for multiple pathogens
which is often seen in cases of co-infection or identify individual pathogens that present
with similar clinical symptoms. Also, all microarray experiments can be run using the
same repeatable techniques and experimental conditions. A limitation to many
microarray detection assays is the requirement of PCR amplification of the target
sequences prior to hybridization.73 Without this amplification, detection is often limited.
This limitation creates a challenge when designing a microarray assay that is not species-
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specific. This limitation is usually overcome through the use of non-specific universal
primers.
Unfortunately, microarray technology is currently associated with high cost.
However, since multiple conventional tests are sometimes required to correctly identify
all pathogens in a disease syndrome,1 the cost of multiple tests could easily be more
expensive than the cost of a single microarray test. Ultimately, a single microarray could
provide diagnostic answers in a time-efficient and cost-effective manner compared to
potential multiple diagnostic tests that could otherwise be required.
Microarrays
Microarray assays are relatively new technology that is finding rapid approval and
widespread application. Microarrays are flat solid surfaces, usually glass, that contain
numerous sequences of nucleotides (probes) that are physically and systematically bound
perpendicularly to the surface in known locations. These probes, varying in length from
as small as 18 bases to hundreds of bases long, represent known regions of a genome, and
usually correspond to specific genes. Samples of either DNA or ribonucleic acids (RNA)
are isolated from biological samples and labeled enzymatically with a fluorescent
molecular tag and, in this report, termed as “target.” The labeled target is hybridized to
the array by binding the target DNA/RNA to a complimentary probe sequence via basepair binding. Fluorescent molecular tags can then be quantitatively measured at each
probe location to determine the relative amount of each target sequence present in an
extracted DNA/RNA sample. The power of microarray technology is the ability to
analyze tens of thousands of genes (or gene sequences) simultaneously in a single
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experiment.23,47 The primary function of microarray technology is for gene expression
profiling, but other applications include identification of potential drug targets, detection
of mutations or single nucleotide polymorphisms, detection of short tandom repeats,
detection of sequence insertions and deletions, comparative genomic hybridization, and
the identification of genomes or parts of genomes (ie. bacterial, viral).32
History of Microarray Technology
In the late 1970s, the first parallel hybridization analysis experiments, known as
the dot blots, were introduced43 to the scientific world by taking advantage of an earlier
idea to use multiple DNA libraries arrayed on filters to cross-correlate cloned
sequences.68 Creating these dot blots was a manual procedure that was improved in the
early 1990s by using robotics to spot probes on filter surfaces which allowed greater
spotting density, accuracy, and speed, while at the same time reducing human error.36
Microarrays became more defined as further improvements were introduced in robotic
spotting technique, and in spotting material, such as glass, polypropylene, nylon, and
silicon, that enabled an increase in production, spotting density, and in some cases, costeffectiveness.68 Microarrays were generally produced in-house for much of the 1990s,
but some laboratories were able to commercialize their specialized version of the
microarray. In 1996, Affymetrix (Santa Clara, California, USA) began to mass-produce
and commercialize their microarray platform, called the GeneChip. Instead of spotting
nucleotides, however, they introduced a new technique by synthesizing short
oligonucleotides directly onto a glass surface using proprietary photolithographic
techniques.50 Other major companies followed with their own designs. For example,
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Agilent Technologies (Santa Clara, California, USA) builds longer oligonucleotides on a
glass slide using inkjet printing technology and phosphoramidite chemistry.38 Over the
years, there has been a decrease in the production of in-house spotted arrays as scientists
refer to more reliable and consistent commercial arrays, though research labs still
commonly produce in-house arrays in an attempt to keep expenses down.
Different Microarray Platforms
As microarray technology has developed, different strategies for microarray
design have emerged from both academic and commercial groups. Many of the
“homemade” in-house spotted arrays initially employed long cloned cDNA samples as
probes, each of which most often represented an entire gene.66 However, the use of
cDNA clones as probes have diminished due to concerns about annotation, clone identity,
and probe performance. The use of oligonucleotides as probes has found greater
popularity, especially among commercial platforms, as these probes have shown better
hybridization characteristics and companies have been able to provide reliable libraries
containing the annotation and identity of the oligonucleotides.77
Currently, most array platforms utilize either a one-color or two-color dye system.
The spotted cDNA arrays regularly use the two-color dye system, in which two samples,
each labeled with different fluorescent tags such as cyanine-3 (Cy3) and cyanine-5 (Cy5),
are hybridized to a single array.66 Hybridizing two samples, a control and a treatment, to
one array provides an advantage by removing array-to-array variability that would
otherwise need to be dealt with when comparing two samples on two arrays. A third
fluorescent dye (fluorescein) can also be used to help monitor quality control measures
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with prehybridization variables.33,34
Affymetrix GeneChips are a one-color platform in which a single sample is
hybridized to a single array. These GeneChips are built with a series of short 25-mer
oligonucleotide probes that represent the genes within a genome. These oligonucleotides
have a greater performance over the much longer cDNA probes, but multiple probes
grouped in a probe set (which usually represents one gene) are required to overcome the
lack of specificity of a 25-mer sequence and increase the overall confidence level. These
probe sets usually contain between 11-20 probes per probe set. Thus, the GeneChips
exhibit a much higher density, up to 1,000,000 probes/cm2,6 even though the human
genome only contains 30,000 genes. Array-to-array variability is reduced through
carefully controlled array production and hybridization methods.6
Agilent Technologies has more recently produced its own line of oligonucleotide
microarrays that use the two-color platform. The Agilent arrays carry longer 60-mer
oligonucleotide probes, which they claim allow for higher specificity compared to the
smaller (Affymetrix GeneChip) probes.38 Also, their arrays, which can contain as many
as 44,000 features, do not require as high a density coverage as the GeneChips. Longer
probes inkjet technology allow for a more cost-effective production of commercial
microarrays.
In one study comparing the performance of three commercial microarrays,
Affymetrix Genechips (short oligonucleotides, one-color platform), GE Healthcare
CodeLink Microarrays (Tempe, Arizona, USA) (long oligonucleotides, one-color
platform), and Agilent microarrays (long oligonucleotides, two-color platform)), it was
reported that there was a higher level of reproducibility from one-color based arrays
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(Affymetrix GeneChips and GE Healthcare CodeLink Microarrays) compared to the twocolored Agilent platform. Furthermore, Affymetrix had higher overall concordance with
same-sample qPCR results.20 Despite this single study, there seems to be no clear
consensus as to which platform performs the best or whether the different platforms are
even comparable. Various studies claim major differences in the data produced,46,64,69
while others insist that there is ample levels of concordance among the different
platforms.39,79
Microarray Applications in Human and Animal Diagnostics
Microarray technology has been applied in both human and animal health studies.
For example, microarrays have been used to profile the expression of genes at different
stages of cancer,22,31,41,67 profile gene expression of neurological diseases such as
Alzheimer’s disease,4,18,21,35 and identify infectious diseases.13,16,59 Additional uses of
microarray technology in human studies include drug discovery, pharmacogenomics, and
toxicogenomics studies,10,19,76 as well as identifying hypothetical genes that might trigger
health-related issues, like obesity, alcoholism, and drug addiction.24
Microarrays have been used more in human related clinical applications than
animal studies. Nevertheless, microarrays have played a significant role in profiling the
gene expression patterns of animal diseases, usually only as starting points for data
mining, to be followed later by more specific tests. Beyond gene expression experiments,
the most common use of microarrays in animal health has been in the detection and
genotyping of animal pathogens.8,9,11,60,72 A less widely used application is directmutation screening for single-gene diseases in dogs, horses, and some livestock.55 In all
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these applications, continued development of genomic maps of individual species will
provide the resources necessary to further animal health studies in the future60 and may
even allow microarray technology to assist in breeding decisions.25
Hybridization and Washing
Hybridization is the formation of heteroduplex molecules when a target and probe
bind together. Under perfect conditions, the target will only hybridize to a probe that is
perfectly complimentary. Therefore, it is possible to determine the sequence of a target,
since the probe has known sequence information and a known location, both on the array
and within a genome. However, microarray experiments are anything but perfect. There
are various conditions that will affect hybridization efficiency. These conditions include
hybridization temperatures, the concentration of monovalent cations such as sodium, the
respective concentrations of the target and probe, GC content, and buffer content.
Optimal hybridization temperature is generally lower than the calculated melting
temperature of the probe sequence. However, while the melting temperature can give an
estimate, optimal hybridization temperature must be experimentally determined. A lower
temperature will result in an increase of non-specific binding, while a higher temperature
will reduce true signal.
All nucleotide molecules are composed of a negatively charged phosphate
backbone, which can impede heteroduplex formation. To negate this hindrance,
monovalent cations, such as sodium, can be added to bind to the negatively charged
phosphates. A salt concentration of one molar is generally sufficient for most microarray
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experiments.45 Adjustment of the salt concentration can help to optimize hybridization,
but such changes are usually small and insignificant.
The concentrations of both the targets and the probes in a hybridization reaction
are important to consider. Hybridization reactions follow either pseudo-first order or
second order reaction kinetics.29 When the target concentration is equal to or less than
the probe concentration, second-order kinetics is achieved.29 Under these conditions,
small differences in the concentration of either the target or probe can have a large impact
on the reaction rate of hybridization. When the concentration of the target is sufficiently
higher than that of the cognate probe, pseudo-first order reaction kinetics is achieved and
the target signal will be directly proportional to that of the target concentration.29
Therefore, a 2-fold increase of target will produce a 2-fold increase in signal. It can be
difficult to build microarrays with precise concentrations of probe, as well as adding the
exact amount of target to a hybridization reaction due to imprecise measurements and
manufacturing techniques. At least a 10-fold greater target concentration than probe is
necessary to achieve such a reaction rate that variations due to imprecise microarray
manufacturing methods can be minimized.29
A post-hybridization wash is necessary to remove unbound target strands from the
array. The wash consists of the array being soaked in two stringent salt solutions, the
first more stringent than the second, with some type of agitation to help “clean” the array.
Optimal stringency of the wash solutions is necessary to not only efficiently remove
unbound target strands, but to also unbind random non-complimentary target/probe
heteroduplexes. Stringency is adjusted through salt concentrations and wash
temperatures. If the stringency of the wash conditions is too low, nonspecific binding
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will increase creating false signals. Relatively high-stringency conditions will give the
best reproducibility.45
Labeling Techniques
Attachment of a fluorescent molecule to a target sample, often termed “labeling,”
requires the use of various techniques and materials. Company provided protocols are
followed when using commercial arrays, but with in-house arrays, a variety of options are
available and the best choice to use tends to be determined by the type of experiments
being performed. Historically, all target samples were initially labeled in a direct
manner, in which nucleotides attached to a fluorescent dye are incorporated into cDNA
through reverse transcription. The fluorescent dyes, like the commonly used Cy3 and
Cy5 dyes, are attached to one of the four nucleotides, usually dTTPs or dCTPs, and
become incorporated into the cDNA at the complimentary dATP (or dGTP) position of
the mRNA strands. However, there are some problems associated with direct labeling.
First, the number of fluorescent molecules that are incorporated into a cDNA strand are
directly proportional to the number of complimentary nucleotides in the mRNA strand.
In the case of Cy3-conjugated dTTPs, the number of Cy3 molecules incorporated into a
cDNA strand will vary based on the number of dATPs in the mRNA strand, and longer
transcripts will invariably have a stronger signal potential than shorter transcripts.
Second, the fluorescent molecules are bulky and tend to create interference during
reverse transcription.58 The result is a variation in labeling efficiency among different
transcripts. Third, mostly in response to the second issue, direct-labeling protocols can
call for up to 50-100µg of starting total RNA. These large amounts of total RNA can be
difficult to produce and are not typically ideal for most clinical applications. One method
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used to circumnavigate this problem has been to amplify RNA prior to labeling,53,54,62,74
but the extent of accuracy and precision of that approach is still under question.
Recently, other labeling techniques have become popular including an indirect
method of labeling cDNA. In this method, amino-modified (amino-allyl) nucleotides,
instead of fluorescent-conjugated nucleotides, are incorporated into the cDNA through
reverse transcription. Once more, only one of the four nucleotides is modified. These
amino-allyl nucleotides are considerably less bulky and thus are incorporated with greater
efficiency. The reactive fluorescent Cy3 and Cy5 dyes are then conjugated to the aminoallyl nucleotides though a chemical coupling step. Labeling efficiency is much higher in
an indirect labeling approach; however, this does not resolve the issues of base
composition or length of transcripts. Direct labeling still offers one advantage over
indirect labeling in that the direct approach is almost always less expensive than the
indirect approach.
Genomic DNA (gDNA) can also be labeled with a fluorophore using direct or
indirect techniques. The fluorophores are incorporated through PCR instead of reverse
transcription. An alternative approach would be to add the fluorophore enzymatically at
the end of a DNA strand using terminal transferase. Terminal labeling is useful when
labeling small strands of DNA where PCR would be difficult. While this approach
would attach only one fluorescent molecule to each strand, the problem of fluorescence
intensity due to base composition and transcript length is eliminated.
Cy3 and Cy5 have been commonly used in microarray experiments as the
fluorophores of choice, however, there are others on the market that claim a superior
performance. The Alexa Fluor family from Invitrogen (Carlsbad, California, USA) is
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one example. The claim is that the conjugates of Alexa 546 fluoresce are at least twice as
bright as that of the Cy3 conjugates.63 Affymetrix uses a fluorophore from the
streptavidin family, which has a very strong affinity for biotin. Using an entirely
different approach, Affymetrix protocols create cDNA from mRNA through reverse
transcription, as is standard, but then continue to produce large amounts of cRNA
through in vitro transcription. During this amplification process, mRNA is amplified
100-fold7 allowing for large amounts of cRNA to be hybridized to a GeneChip. In
addition to amplification, the transcription step also incorporates biotinylated nucleotides.
The biotinylated cRNA is first hybridized to the arrays and then coupled with streptavidin
phycoerythrin to provide the fluorescent signal. To further increase the signal strength,
biotinylated antibodies are attached to the streptavidin phycoerythrin and more
streptavidin phycoerythrin is added to the mixture to bind to the biotin on the antibodies.
Bacterial Pathogens
Bovine diseases are usually identified through a combination of clinical
observations made by veterinarians and ranchers and diagnostic tests performed in a
laboratory. A description of clinical signs and symptoms of the diseases studied in this
project, the causative pathogens, and current techniques employed to detect them are
provided in order to help convey the impact that the pathogens have on livestock and why
further advancement in detection techniques for these pathogens is important. Though
the following are descriptions of individual pathogens and the related diseases, it is
important to note that, in terms of respiratory diseases, it is common for multiple
pathogens to be involved.
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The following pathogens were selected for this project because they are common
causes of infection afflicting livestock each year in the U.S. These diseases are generally
not found in U.S. livestock in epidemic form, but rather as common diseases encountered
of importance to U.S. livestock. U.S. ranchers regularly report individual or group cases,
and local veterinarians, veterinary diagnostic laboratories and the ranchers themselves
usually deal with these cases as they arise. Often, the course of action is to isolate
infected cattle to limit the spread of disease and treat animals accordingly.
Pasteurella multocida
Pasteurella multocida subspecies multocida is the primary pathogen responsible
for hemorrhagic septicemia in cattle, a disease that targets the respiratory system and
causes excessive salivation and nasal discharge with swelling in the pharyngeal and
ventral cervical regions. Cattle with hemorrhagic septicemia usually die within 24 hours
of the first recognizable signs due to respiratory distress. Post-mortem observations
include visible congestion of the mucous membranes, widely distributed lesions and
hemorrhage and edema of the tissues of the head and neck.12
Laboratory diagnosis includes bacterial isolation from heparinized blood or select
tissues, biochemical testing, special staining and observing colony characteristics.
Moreover, there are immunological tests that include a rapid slide agglutination test for
capsular typing, an indirect hemagglutination test for somatic typing, agar gel
immunodiffusion tests, and counter immunoelectrophoresis that can identify the
pathogenic P. multocida serotypes.1 PCR techniques have also been developed to detect
P. multocida in tissue.14,49,56,70
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Histophilus somni (Haemophilus somnus)
Historically thought of primarily as a nervous system pathogen that causes
thromboembolic meningoencephalitis (TEME), Histophilus somni has the ability to
attack numerous different cell types within a cow’s body. Thus the disease is now
referred to as the “Haemophilus somnus complex.” The respiratory form of the disease
causes severe pneumonia and death. The reproductive and urinary tract form leads to
long-term urinary tract infections and can cause abortions. The septicemic form is
manifested by many different clinical signs. There are also miscellaneous forms of the
disease that can infect such systems as the eyes and ears. Ultimately, if left untreated,
one form of the disease can lead to other forms of the disease.44
Current techniques for diagnosis greatly rely on clinical signs and bacterial
culture. Ancillary serological tests are available including a microagglutination test, tube
agglutination tests, a complement fixation test, an ELISA, and a technique that identifies
a H. somni antigen by using monoclonal antibodies.44 A PCR test for the detection of H.
somni in pure and mixed cultures has also been suggested, but is not cost-effective when
compared to microbiological diagnostic techniques.3
Mannheimia (Pasteurella) haemolytica
Mannheimia haemolytica, along with P. multocida, is one of the primary
pathogens responsible for pneumonic pasteurellosis, commonly known as “shipping
fever.” M. haemolytica normally resides in the upper respiratory tract of a cow and tends
to become pathogenic during suppression of the immune system, often a result of stress
(e.g. during shipping) and concurrent viral infections. The disease is typically observed
in feeder calves and can range from acute to chronic conditions with morbidity levels
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reaching 35% and mortality between 5-10%. Diagnosis primarily relies on bacterial
isolation in conjunction with clinical assessment2 and histopathologic examination. A
PCR test that isolates the lkt gene in M. haemolytica has also been demonstrated, but it
lacks species specificity.26,30
Arcanobacterium (Actinomyces) pyogenes
Arcanobacterium pyogenes is an opportunistic pathogen responsible for a wide
variety of diseases, from arthritis, to mastitis, to pneumonia. Abscesses are often
associated with A. pyogenes infections, and can target almost every organ and tissue in a
cow. Diagnosis is primarily confirmed by isolation of the bacterium from the infected
tissue.17
Escherichia coli
Escherichia coli is the most predominant species of normal flora within the
bovine intestine. Most strains are non-pathogenic, however, pathogenic strains cause
severe disease in young animals. Young calves (1-10 weeks) are the most susceptible to
pathogenic E. coli infections, which commonly include enteritis (white scours, enteric
colibacillosis) and septicemia (colisepticaemia). Enteric colibacillosis is primarily caused
by Enterotoxigenic E. coli (ETEC) infections. Calves are also subject to
Enterohaemorrhagic E. coli (EHEC) infections, which include the highly pathogenic E.
coli O157:H7 strain, and Enteropathogenic E. coli (EPEC) infections.
Historically, diagnosis of E. coli infections required positive culture of the
pathogenic species in conjunction with gross clinical evidence such as systemic lesions.
While culture is still useful in identifying E. coli strains, current techniques like PCR are
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widely used for diagnostic detection of pathogenic species61 using virulence gene
identification.
Salmonella typhimurium and Salmonella dublin
Bovine salmonellosis is caused by a number of different serovors of Salmonella
species. However, the most incriminating Salmonella by far found in cases of bovine
salmonellosis are typhimurium and dublin. Salmonellosis usually manifests as septicemia
or acute or chronic enterocolitis. Salmonellosis is highly contagious as the Salmonella
species are resilient in the environment. The enteric syndrome of salmonellosis is more
common in cattle overall, and the septicemic syndrome is more common in calves. S.
dublin is observed more often in the septicemic syndrome of the illness. Septicemic
salmonellosis has a much higher death rate than the enteric syndrome, however, enteric
salmonsellosis still has a fatality rate of about 50% or greater.
Diagnosis is based on a combination of antemortem and postmortem diagnostics
including culture of the organism. Salmonella sp. can be isolated from tissue or fecal
material and from blood in septicemic cases. Serological tests (ELISA, serum
agglutination, complement fixation) are also available for antemortem Salmonella sp.
detection, as well as antibody detection in septicemic animals.71
Objectives of This Report
The objective of this project was to correctly identify the above bovine pathogens
individually from tissue spiked with a mixture of bacteria using microarray technology.
Therefore, two arrays were designed using completely different approaches. A subobjective to this project was to successfully design the arrays for detection of pathogenic
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DNA without a need for PCR amplification. Our first arrays were homemade and
designed in-house using equipment and materials that were available in the Center for
Integrated BioSystems (CIB) at USU. These arrays had probes that targeted the 16S
ribosomal RNA (rRNA) gene for each pathogen. Commercial GeneChips from
Affymetrix were utilized for our second array design. Numerous genes, including the
16S rRNA gene, were represented on these arrays for each pathogen. While the genes
represented on this array were selected in-house, Affymetrix designed the probes and
built the actual arrays. This report covers the research performed using both array
platforms.
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CHAPTER II
IN-HOUSE ARRAYS
Introduction
Our aim was to design and build an in-house microarray for the detection of
common bovine pathogens in a cost-effective manner using equipment and materials that
were available at the CIB. In a study that compared a number of different slide types, the
nylon-mounted membrane slides seemed to provide the lowest detection limit capabilities
while providing the highest signal-to-noise ratios.28 An additional advantage of nylonmounted slides is they are generally less expensive among different slide types and are
adaptable to multiple protocols that use common reagents found in most laboratories.
The array was designed to detect Pasteurella multocida, Manheimia haemolytica,
Histophilus somni, and Arcanobacterium pyogenes, common pulmonary pathogens that
afflict U.S. livestock, using their 16S ribosomal RNA genes for differentiation. These
pathogens were individually hybridized to the designed array to determine if the array
would be sufficient for further testing with bovine tissue.
Materials and Methods
Designing Probes
The 16S ribosomal RNA gene was used to distinguish between different
pathogens. 16S sequence for each pathogen was obtained from GenBank. Numerous
16S gene sequences were obtained for the same pathogen representing different strains
available from GenBank (Table 1). Sequences were aligned using Invitrogen’s Vector
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NTI software. For each pathogen, six regions of the 16S gene were manually selected for
use in the design of target probes. The regions selected were homologous with other 16S
sequences of the same pathogen species, but unique from the 16S sequences of the other
pathogens. For each region, both the sense and anti-sense sequences were used to design
complimentary probes (designated A and B). This allowed for a total of twelve different
sequences to be used for probe design for each pathogen (Table 2). Sequences were 2022 bases in length with a calculated melting temperature of 55°C± 1°C according to
Vector NTI calculations. Integrated DNA Technology (IDT, Coralville, IA) synthesized
the sequences for the probes. Mismatched probes were also designed for each probe
sequence to help differentiate positive signal from background noise by changing two
nucleotides with their compliment. The positions of these changes were manually
selected, based on maintaining a melting temperature of ±+- 1 °C difference from that of
the perfect matched sequence. Mismatched probes are designated with a “MM” in table
2.
Table 1. List of GenBank Sequences Aligned to Select Probes for In-house Arrays
A. pyogenes

ACYRR16S X79225

H. somni

AF031936
AF549387
AF549388
AF549391

AF549392
AF549393
AF549394
AF549395

AF549396
AF549397
AF549398
AF549399

AF549400
AF549401
AF549403
AF549404
M75046

M. haemolytica M75080
M75063

PHU57066 PHU57069 PHU57071
PHU57068 PHU57070 PHU57072

P. multocida

AY299306
AY299307
AY299308
AY299309
AY299311
AY299313
AY299315

AY078996
AY078997
AY078998
AY078999
AY079000
AY299304
AY299305

AY299316
AY299317
AY299318
AY299319
AY324032
AY683485
AY999017

DQ286927
DQ286928
DQ286929
DQ288145
DQ288146
M35018
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Table 2. Position and Sequence of In-house Array Probes
Well
Position
A01

Probe Name

Sequence

M. haemolytica 16S 1A

TGGAGGGGGATAACTACTGG

A02

M. haemolytica 16S 1A MM

TCGAGGGGGATAACTACTCG

A03

M. haemolytica 16S 1B

CCAGTAGTTATCCCCCTCCA

A04

M. haemolytica 16S 1B MM

CGAGTAGTTATCCCCCTCGA

A05

M. haemolytica 16S 2A

TTGGTGAGGTAAAGGCTCAC

A06

M. haemolytica 16S 2A MM

TTGGTCACGTAAAGGCTCAC

A07

M. haemolytica 16S 2B

GTGAGCCTTTACCTCACCAA

A08

M. haemolytica 16S 2B MM

GTGACCCTTTACGTCACCAA

A09

M. haemolytica 16S 3A

CAGTCGATTGACGTTAATCACA

A10

M. haemolytica 16S 3A MM

CAGTCGATTGACGTTAATGAGA

A11

M. haemolytica 16S 3B

TGTGATTAACGTCAATCGACTG

A12

M. haemolytica 16S 3B MM

TGTCATTAAGGTCAATCGACTG

B01

M. haemolytica 16S 4A

GCCATAAGATGAGCCCAAGT

B02

M. haemolytica 16S 4A MM

GCCATAAGATCAGCCCAACT

B03

M. haemolytica 16S 4B

ACTTGGGCTCATCTTATGGC

B04

M. haemolytica 16S 4B MM

ACTTCGGCTCATCTTATGCC

B05

M. haemolytica 16S 5A

AAAGGGTGGGACTTTCGG

B06

M. haemolytica 16S 5A MM

AAAGGGTGGGAGTTTCCG

B07

M. haemolytica 16S 5B

CCGAAAGTCCCACCCTTT

B08

M. haemolytica 16S 5B MM

CCCAAAGTCCCAGCCTTT

B09

M. haemolytica 16S 6A

AGCTGTAAGGTGGAGCGAAT
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B10

M. haemolytica 16S 6A MM

AGCTGTAAGCTGGACCGAAT

B11

M. haemolytica 16S 6B

ATTCGCTCCACCTTACAGCT

B12

M. haemolytica 16S 6B MM

ATTCGCTCCAGCTTACACCT

C01

H. somni 16S 1A

GTGATGAGGAAGGCGATTAGT

C02

H. somni 16S 1A MM

GTCATCAGGAAGGCGATTAGT

C03

H. somni 16S 1B

ACTAATCGCCTTCCTCATCAC

C04

H. somni 16S 1B MM

ACTAATCGCCTTCCTGATGAC

C05

H. somni 16S 2A

AGCATGTTAGGGTGGGAACT

C06

H. somni 16S 2A MM

AGCATCTTACGGTGGGAACT

C07

H. somni 16S 2B

AGTTCCCACCCTAACATGCT

C08

H. somni 16S 2B MM

AGTTCCCACCGTAAGATGCT

C09

H. somni 16S 3A

CACGCAGGTGGTGACTTAAG

C10

H. somni 16S 3A MM

CAGGCAGCTGGTGACTTAAG

C11

H. somni 16S 3B

CTTAAGTCACCACCTGCGTG

C12

H. somni 16S 3B MM

CTTAAGTCACCAGCTGCCTG

D01

H. somni 16S 4A

CAGCATTTCAGACTGGGTGA

D02

H. somni 16S 4A MM

CACCATTTCAGAGTGGGTGA

D03

H. somni 16S 4B

TCACCCAGTCTGAAATGCTG

D04

H. somni 16S 4B MM

TCACCCACTCTGAAATGGTG

D05

H. somni 16S 5A

AGATACTGACGCTCGAGTGC

D06

H. somni 16S 5A MM

AGATACTCACGCTGGAGTGC

D07

H. somni 16S 5B

GCACTCGAGCGTCAGTATCT

D08

H. somni 16S 5B MM

GCACTCCAGCGTGAGTATCT

D09

H. somni 16S 6A

CAGAGATGGTGGTGTGCCTA

D10

H. somni 16S 6A MM

CACAGATGGTGGTCTGGCTA
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D11

H. somni 16S 6B

TAGGCACACCACCATCTCTG

D12

H. somni 16S 6B MM

TAGCCACACCACCATCTGTG

E01

A. pyogenes 16S 1A

CCTTGTCTTTGGGATAAGCC

E02

A. pyogenes 16S 1A MM

CCTTCTCTTTCGGATAAGCC

E03

A. pyogenes 16S 1B

GGCTTATCCCAAAGACAAGG

E04

A. pyogenes 16S 1B MM

GGGTTATCCCAAACACAAGG

E05

A. pyogenes 16S 2A

GAGTGTGGTAGGGGTAATTGG

E06

A. pyogenes 16S 2A MM

GAGTCTGGTAGCGGTAATTGG

E07

A. pyogenes 16S 2B

CCAATTACCCCTACCACACTC

E08

A. pyogenes 16S 2B MM

CCAATTAGCCCTACGACACTC

E09

A. pyogenes 16S 3A

GGTTACTGGGCCATTACTGAC

E10

A. pyogenes 16S 3A MM

GGTTAGTGGCCCATTACTGAC

E11

A. pyogenes 16S 3B

GTCAGTAATGGCCCAGTAACC

E12

A. pyogenes 16S 3B MM

GTCAGTAATGGCCGACTAACC

F01

A. pyogenes 16S 4A

GGCTTGACATACACTGCGAT

F02

A. pyogenes 16S 4A MM

GGCTTCACATACACTGCCAT

F03

A. pyogenes 16S 4B

ATCGCAGTGTATGTCAAGCC

F04

A. pyogenes 16S 4B MM

ATCGCACTGTATGTGAAGCC

F05

A. pyogenes 16S 5A

GTGGTGTACAGGTGGTGCAT

F06

A. pyogenes 16S 5A MM

GTGGTGTACAGCTGCTGCAT

F07

A. pyogenes 16S 5B

ATGCACCACCTGTACACCAC

F08

A. pyogenes 16S 5B MM

ATGCACCACGTGTAGACCAC

F09

A. pyogenes 16S 6A

GCCTGTGAGGGTGAGCTAAT

F10

A. pyogenes 16S 6A MM

GCCTGTGAGGCTGAGGTAAT

F11

A. pyogenes 16S 6B

ATTAGCTCACCCTCACAGGC
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F12

A. pyogenes 16S 6B MM

ATTAGCTCACCCTGAGAGGC

G01

P. multocida 16S 1A

TAACTGTGGGAAACTGCAGC

G02

P. multocida 16S 1A MM

TAACTGTGGCAAACTGGAGC

G03

P. multocida 16S 1B

GCTGCAGTTTCCCACAGTTA

G04

P. multocida 16S 1B MM

GCTGCACTTTCCCACACTTA

G05

P. multocida 16S 2A

CGGTAATGAGGAAGGGATGT

G06

P. multocida 16S 2A MM

CGGTTATCAGGAAGGGATGT

G07

P. multocida 16S 2B

ACATCCCTTCCTCATTACCG

G08

P. multocida 16S 2B MM

ACATCCCTTCCTGATAACCG

G09

P. multocida 16S 3A

ATTTGGGGATTGGGCTATAT

G10

P. multocida 16S 3A MM

ATTTGGGCATTGGCCTATAT

G11

P. multocida 16S 3B

ATATAGCCCAATCCCCAAAT

G12

P. multocida 16S 3B MM

ATATAGCCCAATGGCCAAAT

H01

P. multocida 16S 4A

GACTGCCAGTGACAAACTGG

H02

P. multocida 16S 4A MM

GACTGCCAGTGAGAAAGTGG

H03

P. multocida 16S 4B

CCAGTTTGTCACTGGCAGTC

H04

P. multocida 16S 4B MM

CCAGTTTGTGACTGGGAGTC

H05

P. multocida 16S 5A

CTCAGAGATGAGCTTGTGCC

H06

P. multocida 16S 5A MM

CTCAGAGATCACCTTGTGCC

H07

P. multocida 16S 5B

GGCACAAGCTCATCTCTGAG

H08

P. multocida 16S 5B MM

GGCAGAAGCTCATGTCTGAG

H09

P. multocida 16S 6A

ATACAGAGGGCAGCGAGAGT

H10

P. multocida 16S 6A MM

ATACAGAGGCCACCGAGAGT

H11

P. multocida 16S 6B

ACTCTCGCTGCCCTCTGTAT

H12

P. multocida 16S 6B MM

ACTGTCGGTGCCCTCTGTAT
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Tailing Probes
A polyinosine tail was added to each oligonucleotide probe using terminal
transferase.78 12nmols of each probe was synthesized by IDT in a deep-well 96-well
plate. Probes were diluted with TE buffer (pH 7.0) to a 10µM concentration. The probes
were then tailed with dITPs in a 20µl reaction that contained 10µl of 10µM probe
oligonucleotides (IDT), 4µl 25mM CoCl (New England Biolabs, Ipswich, MA), 1µl
20U/µl TdT (New England Biolabs), 4µl 5X TdT buffer (New England Biolabs), and 1µl
10µM dITP (Roche Applied Science, Foster City, CA). The reaction was incubated at
37°C for 2 hours and then allowed to freeze at -20°C overnight. After freezing, the
reaction was thawed in a biological safety cabinet and allowed to completely evaporate
for 24 hours. After evaporation was complete, the oligonucleotide probes were
reconstituted in a 1X TE buffer (pH 7.0) with 5% glycerol solution. This TE
buffer/glycerol solution helped to prevent evaporation of the probe solution during
spotting of the microarrays.
Spotting Microarrays
Vivid microarray slides (Pall, East Hills, NY) were used as the platform for our
experiments. The Vivid arrays have a thin uniform nylon membrane that covers the glass
slide, which is reported to improve the target/probe binding and reduces background over
traditional glass slides.28 The Vivid slides were spotted with a QArraymini spotter
(Genetix, Queensway, UK) following the manufacturer’s protocol using solid pins and
were spotted at 10°C at 50% humidity.
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Culturing Pathogens
Pure cultures of the pathogens were obtained from the American Type Culture
Collection (ATCC, Manassas, VA). A list of ATCC numbers is found in Table 3.
Bacteria were streaked onto blood agar plates and were incubated under aerobic
conditions at 37°C for 24-48 hours depending on the growth rate of each bacterial
species. Individual colony forming units (CFU) were selected for DNA extraction as
needed. The only exception was that A. pyogenes was incubated under anaerobic
conditions. All of the pathogens were isolated in pure culture the Utah Veterinary
Diagnostics Laboratories (UVDL), Logan, UT. PCR was used to confirm bacterial
identity after DNA was extracted.
Table 3. ATCC Numbers of Pathogens for In-house Arrays
Pathogen

ATCC #

P. multocida

12945

M. haemolytica

55518

H. somni

700025

A. pyogenes

49698

Extracting DNA
DNA was extracted from bacterial CFU’s by lysing the cells with CTAB and
purifying the DNA using a phenol/chloroform separation.5 DNA concentration and
purity ratios were measured using a ND-1000 spectrophotometer (Nanodrop,
Wilmington, DE).
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PCR
PCR was used to confirm the identity of each isolate by amplifying the 16S
ribosomal genes using primers listed on Table 4. Also, as will be discussed later, it was
necessary to amplify the 16S ribosomal gene in each group or sample through PCR prior
to adding a fluorescent label. The initial objective was to achieve sufficient labeling
without prior amplification, but was unsuccessful. The PCR protocol was as follows:
200-300ng of gDNA was added to a 50µl reaction containing 1µl Advantage 2
polymerase (Clontech, Mountain View, CA), 1µl dNTPs (10µM) (New England Biolabs),
1µl 10µM forward and reverse primers (IDT) each, and 5µl 10X buffer (Clontech).
Reactions were initially denatured (95°C-1 min), followed by 30 amplification cycles
(95°C-30s, 57°C-30s, 68°C-3min), and completed with a final extension step (68°C3min). PCR products were run on a 1% TAE gel stained with 0.5X SYBR Safe
(Invitrogen) to confirm successful amplification.
Table 4. Primer Sequences Used to Amplify the 16S Gene of Bovine Pathogens
Pathogen
P. multocida

Primers
F-5’-AACACATGCAAGTCGAACGG
R-5’-TGACGGGCGGTGTGTACAA

M. haemolytica

F-5’-TCAGATTGAACGCTGGCGGC
R-5’-CACACCCCAGTCATGAATCATACCG

H. somni

F-5’-GAGTGGCGGACGGGTGAGTAAA
R-5’-ACTTCTGGTACAACCCACTCCCATG

A. pyogenes

F-5’-GCGTGCTTAACACATGCAAGTCG
R-5’-TCACCGCAGCGTTGCTGATC
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Labeling DNA
16S ribosomal amplicons (2 µg) were labeled with Alexa Fluor 546, because of its
superior fluorescence compared to Cy3,63 using Invitrogen’s BioPrime Plus Array CGH
Indirect Genomic Labeling System. The protocol was followed according to
manufactures’ instructions except the optional DNA digestion step prior to labeling was
skipped and was regarded as unnecessary for this study.
Hybridization, Washing, Scanning
Vivid slides were soaked in a preheated pre-hybridization buffer (100mM NaPO4,
20% SDS, 0.1g Casein) for 30 minutes at 45°C, after which excess buffer was allowed to
run off. A total of 1µg of labeled target was added to a hybridization buffer (100mM
NaPO4, 20% SDS, 0.1g Casein) for a total volume of 100µl. Hybridization cocktail was
heated to 95°C for 5 minutes to denature the DNA. The entire hybridization cocktail,
100µl, was pipetted onto the array, after which a cover slip was laid. Arrays were
incubated in a Boekel Scientific Hybridization Oven (model # 241000) at 45°C for 2
hours. Filter paper soaked with pre-hybridization buffer was laid in the oven to retain
humidity within the chamber. Arrays were washed in a preheated “Wash A” solution
(2X SSC, 0.5% SDS) at a range of temperatures (40°C-55°C) for 30 minutes with
agitation. During this step, cover slips were removed if they did not already slide off by
themselves as a result of shaking. Arrays were then transferred to a preheated “Wash B”
solution (0.5X SSC, 0.5% SDS) and washed at a range of temperatures (40°C-55°C) for
30 minutes with agitation. Arrays were finally transferred to a rinse solution (0.5X SSC)
at room temperature for about 10 seconds with agitation. The slides were dried by
spinning them in 50mL conical tubes in a centrifuge at 3000 rpm for 5 minutes. Arrays
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were immediately scanned with an Axon Genepix 4200A scanner (Molecular Devices
Sunnyvale, CA) with a PMT setting of 400.
Data Analysis
Scanned images of arrays were analyzed with GenePix Pro, v5.1 (Molecular
Devices). For each hybridization spot, a foreground and background signal was
calculated. The foreground signal was then divided by the background signal to get a
signal ratio. A signal ratio of 2 or higher was considered a positive signal.
Results
Layout of In-house Array
The organisms, P. multocida, H. somni, A. pyogenes, and M. haemolytica, are
represented on the in-house array. Each array consisted of 10 repeated regions as shown
in figure 1. Each region was divided into four quadrants. The two left quadrants were
blanks that acted as negative controls for hybridization. The top right quadrant contained
all PM probes for all pathogens, while the bottom right quadrant contained the
corresponding MM probes. Probes representing the 16S ribosomal gene for P. multocida
were located within the 1st and 2nd columns as shown in the red box of figure 1. Probes
for A. pyogenes are found in the 3rd and 4th columns as shown in the yellow box, H. somni
in the 5th and 6th columns as shown in the blue box, and M. haemolytica in the 7th and 8th
columns as shown in the white box. The position of a MM probe matches that of its
corresponding PM probe.
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Figure 1. Layout of the in-house array
A

B

C

D

Figure 1. Layout of the in-house array. Each pathogen is represented by 12 PM probes
and 12 MM probes. Each block of probes is repeated on the array 10 times.
(A) P. multocida (B) A. pyogenes (C) H. somni (D) M. haemolytica
Hybridizing Genomic DNA
The initial aim of this study was to detect proper signals with hybridized gDNA
without amplification. This possibility was tested by hybridizing whole gDNA, sheared
DNA by use of a sonicator, and enzymatically digested DNA using restriction enzyme
RSA. However, this procedure was not able to produce any signal patterns (figure 2), nor
were any significant changes seen with the signal as hybridization and wash conditions
were changed. Ultimately, gDNA signals were so weak that the strongest signals seen in
the images in figure 2 corresponded to the greatest indent on the nylon membrane
inadvertently created from spotting the arrays. Due to these findings, it became
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necessary to amplify the 16S gene for each pathogen through PCR in order to enhance
signal patterns.

Figure 2. Three arrays hybridized with unamplified P. multocida gDNA.
(a) Whole gDNA (b) sheared DNA (c) restriction enzyme-digested DNA.
No signal pattern was detected.
Optimizing Washing Conditions
P. multocida amplified gDNA was hybridized to a series of arrays, all at 45°C.
Wash temperatures were varied from 40°C to 55°C to find an optimal wash temperature.
From a series of experiments, the best hybridizations occurred in wash conditions at 50°C
where the positive signals were consistently easier to distinguish from the background.
As wash temperatures decreased to 45°C and less, an increase in signal was seen for both
PM and MM probes indicating the possibility of non-specific binding. At wash
temperatures higher then 50°C, most of the probes produced lower signals at or near
background levels. Based on these observations and information by Loy et al., 50°C was
chosen as optional wash temperature.51-52
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Hybridization Patterns
Numerous P. multocida arrays were initially run to optimize conditions until a
strong hybridization pattern for P. multocida became apparent (figure 3). With the
exception of probes designated P. multocida 16-3 A&B , all P. multocida probes showed
the highest signals, though the analyzed signal values never reached a level of 2, which
was the designated positive signal threshold. However, despite this limitation, the green
hybridization pattern for P. multocida, within the first two columns in the PM quadrant,
was easily distinguishable from background noise.
As amplified DNA from the other pathogens was introduced to the array, each
produced a hybridization pattern of green spots within the columns of the PM quadrant
corresponding to the correct pathogen. In the arrays hybridized with A. pyogenes DNA,
seven of the twelve probes showed strong signals, most with a value of 2 or greater
(figure 4). However, three MM probes consistently produced high signals, while one of
the counterpart PM probes did not show any signal. Amplified H. somni DNA
hybridized well to its probes as all of the PM probes showed strong signals, though four
were significantly less than the other eight (figure 5). Arrays hybridized with amplified
M. haemolytica DNA seemed to be the least successful (figure 6). Only four probes,
designated M. haemolytica 16-1 A&B and 16-4 A&B, had signal values higher than 2,
which were followed distantly by 16-3 A&B.
Though some random signaling not associated with the target DNA in each of the
arrays was observed, indicating a need for additional optimization, we were mostly
concerned with probes M. haemolytica 16-1 A & 16-4 A, which produced strong signals
in all arrays.
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Figure 3. P. multocida hybridization pattern and signal intensities
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Figure 4. A. pygenes hybridization pattern and signal intensities
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Figure 5. H. somni hybridization pattern and signal intensities
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Figure 6. M. haemolytica hybridization pattern and signal intensities.
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Discussion
Our primary aim in this study was to design a microarray that could correctly
detect specific bovine pathogens within infected cattle tissue. Our secondary objective
was to design a platform that would be relatively inexpensive compared to current
standard microarray costs. The overall aim was to provide an approach that could
potentially challenge current veterinary diagnostic techniques in terms of accuracy, ease,
safety, and cost-effectiveness.
The Good
After much trial and error in finding optimal assay conditions, we successfully
hybridized gDNA from the four pulmonary pathogens, P. multocida, M. haemolytica, H.
somni, and A. pyogenes, to the “in-house” microarray and produce distinct signal patterns
for each pathogen. The probes for each pathogen were arranged such that it was possible
to identify the pathogen hybridized from the signal pattern alone without the need of
additional software analysis.
Not all of the probes designed for specific pathogens demonstrated successful
hybridization with the target DNA. Since this was the first trial phase, and thus only the
first round of elimination, we were not surprised that there were some probes that refused
to hybridize. Overall, hybridization patterns repeated in each of the ten regions and were
also consistent among repeated arrays. With the current data being consistent, we feel it
would be safe to remove the unsuccessful probes from future arrays and use only the
successful probes for diagnostics.
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There were a total of twelve probes for each pathogen that targeted the 16S
ribosomal gene. Probes for P. multocida had the highest success rate with 10 out of 12
showing successful hybridization. Both probe sets for H. somni and A. pyogenes had an
average success rate of 58% (7/12 probes showed successful hybridization), which is
sufficient for positive identification. Probes for M. haemolytica had the lowest success
rate with only 4 out of 12 probes showing successful hybridization. However, two of the
probes that target M. haemolytica also showed varied levels of signal when hybridized
with the other pathogens, making them less useful for diagnosing mixed infections. The
corresponding MM probes also produced a signal that was equal to or less than the PM
probes, and even on the M. haemolytica array, some MM signal was evident for these two
probes. This casts doubt as to whether these M. haemolytica signals were true signals.
We feel that they were false positives created from some unknown hybridization issue,
probably a technical issue, since the signals were evident to some degree in all of the
hybridized arrays.
The Bad
We were able to produce distinct, visible signal patterns that confidently
represented each pathogen, except M. haemolytica. However, there are still additional
challenges that will be faced in any future versions of these in-house arrays. First, though
the probes showed fairly good consistency in terms of whether the probe was successful
or not at producing a signal, there was some signal variation that seemed to be dependant
on the probe’s physical location on the array. The strength of the signal overall tended to
be stronger on one side of the array than the other. As you view the arrays presented in
this report, from top to bottom, the strength of the signal was typically stronger on the
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bottom of the array. We feel this represents a mechanical error with the scanner since
this pattern was consistent with each array regardless of which way the array was inserted
into the scanner. This could certainly be corrected in the future, but no doubt allowed a
bias to enter in the calculations made for the signal strength of each probe during this
series of experiments.
Second, these arrays were prone to random spots, smears, and scars that produced
extra noise as can be seen on the pictures of each array. These extra blemishes affected
the signal of any probes that shared the same physical location with the blemishes on an
array. These blemishes were the result of the arrays being exposed to a “dirty”
environment during processing. The issue could be corrected by improving the
processing protocols and working environment. Taking steps to “clean” the procedure
and working environment should lessen the formation of these blemishes.
All of the previously mentioned obstacles could be resolved with improved
versions of the array through selecting the appropriate probes, optimizing hybridization
conditions, including the working environment, and tuning the necessary equipment. The
third major issue, however, presented a problem that was not expected. One of our initial
aims was to produce positive signal patterns by hybridizing whole gDNA without the
need for extra sample preparation (other than labeling). In our initial attempts, we were
unable to achieve that objective with these arrays. In order to produce the desired
signals, it was necessary to first amplify the 16S gene sequence through PCR using
species-specific primers. In our opinion, this was an unacceptable step in preparing
target DNA. Using this procedure, one could simply identify the bacterial species
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through the PCR amplification step, and further analysis by hybridization of the
amplified sequence to a microarray was only redundant.
Conclusion
We designed, built, and processed our arrays in-house, and were encouraged by
being able to produce distinct signal patterns for each of the hybridized pathogens. We
came across a number of obstacles, both technical and mechanical, but felt that with time
most could be resolved. Our most concerning obstacle was that a positive signal was
only possible by first PCR amplifying the 16S gene sequence. Due to this unforeseen
issue, more efficient array options were explored.
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CHAPTER III
AFFYMETRIX ARRAYS
Introduction
For detection of specific bovine pathogens common in the US we designed a
custom Affymetrix GeneChip, STYLMONOa520430F. We were interested in detecting
pathogens that target various organs; P. multocida, M. haemolytica, H. somni, and A.
pyogenes from the lung and nasal cavities, and S. typhimurium, S. dublin, and E. coli
from the liver, lung, kidney, and spleen. These pathogens were hybridized to the
GeneChip both individually and spiked into bovine tissue prior to extraction and
hybridization.
The STYLMONOa520430F GeneChip was primarily designed for S.
typhimurium strain LT2 and L. monocytogenes strain EGDe, and their entire genomes are
represented on the array, including a series of intergenic regions.75 Of these two
pathogens, only S. typhimurium was of interest in this study. L. monocytogenes genes
were only used to help calculate background signal. For the remaining pathogens, only a
select set of genes were represented due to limited space available on the array.
Material and Methods
Array Design
In total 4639 genes were selected for probe design: 56 genes for P. multocida, 3
genes for M. haemolytica¸ 2 genes for H. somni¸ 2 genes for A. pyogenes, 4518 genes for
S. typhimurium, 8 genes for S. dublin, and 50 genes for E. coli (Appendix A). The
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strategy for probe design depended greatly on whether the specific bacterial genome was
sequenced. Ultimately, probes were designed to be specific to the target bacterium
without significant cross-hybridization. The sequenced genomes of P. multocida Pm70
and E. coli 0157:H7 were run through ERGO (a web-based genome-comparison analysis
program) to identify a list of possible genes from which to design probes for the array.
With that program, the list of potential candidate genes useful for the array was reduced
from thousands to only hundreds for each bacterium.
Select candidate gene sequences were analyzed using BLAST from the National
Center for Biotechnology Information (NCBI) to search for genes that were the most
unique to the target bacterium. Using an E score of 1e-5 as the cutoff for significance,
genes were selected for probe design if they produced a significant hit (<1e-5) with only
that of its target bacterium. If there was a significant match to another organism other
than the target bacterium, the sequence was removed from consideration. According to
Affymetrix standard procedure, probes were to be designed only from within the first 600
bases of a selected gene, so any homologous sequences beyond 600 bases, regardless of
the E score, were ignored. There were a few cases in which genes were selected for
probe design even though the gene sequence had a significant hit (<1e-5) with another
organism besides that of the target bacterium. In these cases, the genes were admitted
only because there was a need for more probes and these other non-target organisms were
not closely related to the target bacterium nor were they related to human, bovine, or
other farm species, and were thus less of a concern for potential contamination.
For M. haemolytica, A. pyogenes, S. dublin, and H. somni, whose genomes are not
yet sequenced, we selected genes based on a review of the literature: lktA26,30 and lpsA
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for M. haemolytica,37 plo for A. pyogenes,42 rpoB for H. somni.57 The H. somni genome
has been sequenced (as of Dec 2006), but was not published at the time the array was
designed. There are only seven sequences available in genbank for S. dublin of which the
functions are unknown. However, since the sequences were specific to S. dublin, all
seven genes were included. In addition to the gene search and literature review, the 16S
and 23S gene sequences were also included for each pathogen.
The S. typimurium LT2 genome was used to design the probes for S.
typhimurium.75 The probe sets designed for S. typhimurium differ from the probe sets of
the other pathogens of interest in that the entire genome is represented instead of a select
number of genes.
Standard Affymetrix protocols for designing GeneChips include the design and
synthesis of MM probes for every probe set. Affymetrix utilizes MM probes to increase
sensitivity in expression arrays by removing background signal caused by higher levels of
non-specific binding as a result of using short oligonucleotide probes. However, since
the STYLMONOa520430F GeneChip was used as a diagnostics array in this study, it
was opted to exclude the MM probes in order to preferably allow more room for PM
probes. Thus this GeneChip contained only PM probes.
Culturing Pathogens
Pure cultures of each bacterium were obtained from either the ATCC or from
environmental strains that were isolated from tissues of cattle at the UVDL. A list of the
sources is found on Table 5. Unless otherwise stated elsewhere in this report, ATCC
strains were hybridized individually to test for cross hybridization, and the field isolates
were spiked into tissue homogenates before DNA extraction and hybridization to confirm
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that specific detection was possible while mixed with Bovine DNA. With the exception
of A. pyogenes, the pathogens were streaked onto blood agar plates and were incubated
under aerobic conditions at 37°C for 24-48 hours depending on the growth rate of the
bacterium. A. pyogenes was incubated under anaerobic conditions. Individual CFUs
were selected for DNA extraction as needed.
Table 5. List of ATCC Numbers of Pathogens for Affymetrix Arrays
Pathogen

ATCC # or Field Isolate

Source

P. multocida

12945

ATCC

55518

ATCC

Field Isolate

UVDL

700025

ATCC

Field Isolate

UVDL

49698

ATCC

Field Isolate

UVDL

35987

ATCC

Field Isolate

UVDL

Field Isolate 1

UVDL

Field Isolate 2

UVDL

35150
Strain O157:H7
Field Isolate 1

ATCC

Field Isolate 2 (078:H11)

UVDL

Field Isolate 3
(Non-pathogenic)

UVDL

M. haemolytica

H. somni

A. pyogenes

S. typhimurium

S. dublin

UVDL

E. coli

45
DNA Extraction
DNA was extracted from each pathogen by lysing the cells with CTAB and
purifying the DNA using a phenol/chloroform separation.5 DNA was also extracted from
bovine lung, kidney, liver, and spleen using QIAGEN’s DNeasy Protocol for Animal
Tissues.
DNA was also extracted using the QIAGEN’s DNeasy Protocol for Animal
Tissue from bovine tissue homogenates that were spiked with bacterial cocktails to
simulate multi-pathogen infections. Ten to 100 CFUs of each bacterium were added to
25 mg of each bovine tissue (10 mg of spleen) before extraction of DNA.
PCR
PCR was used to confirm that specific bacterial DNA was present in the spiked
tissue samples. 200 ng of DNA from the spiked tissue samples was then used as starting
material. The 16S gene of each bacterium was targeted with specific primers (Table 6).
The GoTaq Green Master Mix protocol (Promega; P/N M7122) was followed using 25ul
reactions that were initially denatured (95°C-2 min), followed by 30 amplification cycles
(95°C-30s, 63°C-30s, 72°C-2min), and completed with a final extension step (72°C5min). PCR products were run on a 1% TAE gel stained with 0.5X SYBR Safe
(Invitrogen, P/N S33102).
Labeling
Up to 4 µg of extracted DNA was fragmented in a 20 µl reaction containing
0.6U/µg DNaseI (Amersham Biosciences, P/N 27-0514-01) (diluted in 1X One-Phor-All
Buffer), 2 µl 10X One-Phor-All Buffer (Amersham Biosciences, P/N 27-0901-02), and
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up to 20 µl Nuclease-free water. The reaction was incubated at 37°C for 10 minutes and
inactivated at 98°C for 10 minutes. A portion of the extracted DNA was examined on a
1% TBE gel stained with 1X SYBR Gold (Molecular Probes, P/N S-11494).
The entire fragmented DNA sample was labeled on the 3’ termini in a 50 µl
reaction containing 2 µl of 7.5 mM GeneChip DNA Labeling Reagent (Affymetrix, P/N
900542), 10 µl 5X Reaction Buffer, 2 µl Terminal Deoxynucleotidyl Transferase
(Promega, P/N M1875), and up to 50 µl Nuclease-free water. The reaction was incubated
at 37°C for 1 hour and was stopped with 2 µl of 0.5 M EDTA.
A gel-shift assay was run to verify labeling efficiency. 5 µl of 2 mg/mL
ImmunoPure NeutrAvidin (Pierce Chemical, P/N 31000) was added to a 200 ng aliquot
of labeled DNA and incubated at room temperature for 5 minutes. DNA sample was
loaded onto a 1% TBE gel, after which the gel was stained in 1X SYBR Gold for 10
minutes.
Hybridization, Washing, Scanning
The labeled DNA was diluted in 6.5 µl of 20X Hybridization controls and
Nuclease-free water up to 50 µl. Diluted labeled DNA/Hybridization control mix was
added to a hybridization cocktail and hybridized to the STYLMONOa520430F GeneChip
according to the Affymetrix Prokaryotic Target Hybridization protocol under the 100
format (Midi). The arrays were incubated at 45°C at 50 rpms for 16 hours in a GeneChip
Hybridization Oven 640. Arrays were washed and stained in a GeneChip Fluidics Station
450 and scanned with a GeneChip Scanner 3000. Washing, staining and scanning were
done according to the Affymetrix Prokaryotic Arrays: Washing, Staining, and Scanning
protocol.
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Table 6. Primers Sequences that Target the 16S Gene of Each Pathogen
Pathogen

Primer Sequence
F - 5’-AACACATGCAAGTCGAACGG

P. multocida

R - 5’-TGACGGGCGGTGTGTACAA
F - 5’-TCAGATTGAACGCTGGCGGC

M. haemolytica

R - 5’-CACACCCCAGTCATGAATCATACCG
F - 5’-GAGTGGCGGACGGGTGAGTAAA

H. somni

R - 5’-ACTTCTGGTACAACCCACTCCCATG
F - 5’-GCGTGCTTAACACATGCAAGTCG

A. pyogenes

R - 5’-TCACCGCAGCGTTGCTGATC
F - 5’-GTTTGATCCTGGCTCAGATTGAACG

S. typhimurium

R – 5’-CGGACTACGACGCACTTTATGAGGT
F - 5’-GTTTGATCCTGGCTCAGATTGAACG

S. dublin

R - 5’-TCGCGAGGTCGCTTCTCTTTGT
F - 5’-TTGATCATGGCTCAGATTGAACGC

E. coli

R - 5’-CTAGCGATTCCGACTTCATGGAGTC

Data Analysis
The .cel files generated by the GeneChip Operating Software were processed in
R. Since the arrays did not have MM probes, background was corrected using the Robust
Multi-Array (RMA) average expression method as it was designed to ignore MM signals.
For the datasets that required normalization, we used the “constant” normalization
method in which all of the arrays in a dataset were scaled to a chosen baseline array. All
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datasets were summarized using “pmonly,” which calculated a signal value for each
probe set by averaging the individual probe signals (Appendix B).
The arrays were analyzed by calculating a single signal value for each pathogen
by averaging the probe set signal values. This overall signal value was calculated for
each pathogen on all arrays to see if any of the pathogen probe sets were showing
positive signals on arrays for which the pathogen was not hybridized. Background was
also calculated for each array by averaging the probe set signal values for all non-target
probe sets. For the background value, a select number of probe sets were excluded from
analysis: the hybridization controls, which produced strong positive signals, and probe
sets representing the intergenic regions of L. monocytogenes and S. typhimurium. These
intergenic regions were excluded because they showed significant cross hybridization and
produced strong signals that interfered with analysis. Overall signal value for all
pathogens was compared on each array with the average background signal to determine
whether a pathogen was detected on an array. Ideally, the target pathogen would show a
signal higher than that of the calculated background. Also, the signal values for the
pathogens not targeted on an array would be equivalent to that of the background signal.
Results
GeneChip Validation
Three STYLMONOa520430F arrays were hybridized with unknown
concentrations of P. multocida DNA. The signal values for P. multocida were 224.39,
2438.39, and 164.21 while the signal for background and other pathogens ranged from
0.7 to 2.31 (figure 7). The hybridized arrays were analyzed further by analyzing the
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signal values of the individual probe sets that targeted the different P. multocida genes.
Of the 56 different probe sets that targeted P. multocida, 46 consistently produce positive
signals at various strengths. However, 10 probe sets refused to produce any signal with
all three hybridized arrays (figure 8, shows data from one array). With PCR and primers
designed to amplify those 10 genes represented by the failed probe sets, we determined
that those specific gene sequences were not present in our P. multocida DNA samples.
We also determined that the different probe sets did not respond equally, in that some
probe sets produced stronger signals than other probe sets hybridized with the same DNA
(figure 8).

Figure 7. Validation of STYLMONOa520430F GeneChip using P. multocida.
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Figure 8. Evaluation of P. multocida probe sets.
Detection Limit
We used P. multocida in a series of detection limit experiments. We hybridized
P. multocida to the STYLMONOa520430F array with 1 µg, 500 ng, 250 ng, and 10 ng of
DNA. Each concentration only had 1 replicate except at 250 ng, which had 2 replicates.
This dataset was normalized for comparison and as expected, we saw a decrease in signal
value as we decreased the amount of DNA added to the array. At DNA concentrations of
1000, 500, and 250 ng, the signal value for the P. multocida genes (86.76, 49.75, and
19.97, respectively) was much higher than the background signal (1.39, 1.38, and 1.53,
respectively) (figure 9). The 10 ng DNA concentration did not show a significantly
higher signal at 1.68 than the background at 1.46. To ensure good detection, remaining
experiments were run at a DNA concentration of 250 ng or higher.
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Figure 9. Detection limit of P. multocida.
Probe Set and Cross Hybridization Evaluation
To determine which genes gave positive signals for each bacterium and evaluate
cross hybridization issues, M. haemolytica, H. somni, A. pyogenes, S. dublin, and E. coli
were hybridized to individual STYLMONOa520430F arrays at 250 ng each. Only field
isolates of S. dublin were hybridized. The P. multocida (250 ng) data from the previous
experiment was added to this dataset. DNA from bovine lung, liver, kidney, and spleen
was also hybridized at 250 ng each on a single STYLMONOa520430F array, as a
negative control and to confirm that DNA from bovine tissue would not cross hybridize
to any of the genes on the array. DNA from all bacterial species were hybridized in
duplicates on separate days except S. dublin, which had only one replicate.
All arrays hybridized with P. multocida, A. pyogenes, and S. dublin showed
positive signals for their target bacterial DNA when hybridized with 250 ng of DNA. For
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P. multocida, 46 of 56 genes continued to produce a positive signal. In the two 250 ng
arrays, the target probe sets produced signal values of 26.71 and 13.23 with a background
of 1.60 and 1.47, respectively (figure 10). Signal values for the other pathogens ranged
from 1.20-2.39 on both arrays. Genes designated PM_r01_at and PM_r02_at, which
represent 16S and 23S genes, were among the positive signaling genes.
The arrays hybridized with A. pyogenes DNA had 1 of 2 genes that showed a
positive signal. The two A. pyogenes arrays had target signal values of 7.75 and 4.6 with
backgrounds of 1.28 and 1.48, respectively (figure 11). The 16S gene designated
AP_16S showed strong signals at 14.15 and 7.4 while the published hypothetical genes
designated AP_smc_plo_ftsyY showed no signal at 1.36 and 1.8. Signal values for the
other bacteria ranged from 1.04 - 1.8 on both arrays.
The single S. dublin-hybridized array had a target signal value of 9.39 with a
background of 1.17 (figure 12). S. dublin genes were the most successful of all the
bacterial probe sets in terms of percentage. Only one gene, SD_273, failed to produce a
signal, while the remaining genes produced positive signals of various strengths.
However, this was the only array to show significant cross hybridization with another
pathogen, S. typhimurium, with a signal value of 5.55, which will be discussed later. All
other pathogen signal values ranged from 0.92-1.19.
S. typhimurium DNA was hybridized to the arrays in a previous project. No cross
hybridization to any other bacterial DNA represented on the array was evident.75
M. haemolytica and H. somni did not demonstrate any significant signal above the
background at 250 ng. The two M. haemolytica arrays had target signal values of 1.44
and 1.31 with backgrounds of 1.39 and 1.32 (figure 13). The other pathogenic signal
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values ranged from 1.29-1.65. H. somni signal values were barely detectable at 2.65 and
2.17 with background values of 1.4 and 1.48. Signal values for the other pathogens
ranged from 1.23 to 1.56 (figure 14). To determine if these genes were failing to
hybridize or were simply below their detection limits, we also hybridized 1µg of M.
haemolytica and H. somni DNA. With these increased concentrations, we saw a higher
signal of 34.49 in M. haemolytica (figure 13). However, this signal was only produced
by one of the three genes designated MH_lpsA_at. The remaining two genes,
MH_16S_at and MH_lktA_at, still did not show positive signals with the increased DNA
concentration. H. somni hybridization responded in a similar fashion with the increase in
hybridized DNA. Gene designation HS_rpoB_at produced a stronger signal of 19.37 and
gene designation HS_16S_at produced a moderate signal of 5.5 creating an average of
12.44 (figure 14). Ultimately, 250 ng of DNA was below the detection limit for these
probe sets.
We hybridized three different strains of E. coli to the array (O157 and field
isolates 1 & 3). Two E. coli O157 (1µg)-hybridized arrays produced overall signal
values of 40.28 and 42.88 with backgrounds of 1.14 and 1.11 (figure 15). Neither of the
two field isolates (250 ng) showed strong average signals with values of 2.81 and 1.98
with backgrounds of 1.38 and 1.79 (figure 15). However, both isolates did hybridize to
different individual probes sets. Isolate 1 hybridized strongly to 4 out of 50 E. coli probe
sets, and isolate 3, which was considered non-pathogenic and part of the normal flora of a
cow’s rumen, showed some minor signal with approximately 5 out of 50 E. coli probe
sets (data not shown). If the 45-46 non-hybridized genes are not considered, and only the
positive signals are averaged, signal values of 18.96 and 5.04 for isolates 1 and 3,
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respectively, with backgrounds of 1.38 and 1.79 (figure 15) are recognized. All other
pathogenic signal values ranged from 1.08-2.3. Furthermore, when E. coli probe set
performance was evaluated with 1 µg of DNA from E. coli field isolates 1 & 2, we saw
different hybridization patterns between to the two isolates. We observed the same four
genes showing strong signals with E. coli field isolate 1 DNA as was in previous
experiments, only at higher levels with the increase in target DNA concentration, and five
genes showing signal with field isolate 2. Of the nine probe sets that successfully
hybridized to target DNA, only two of probes sets hybridized with both field isolate 1 and
2 (figure 16). This demonstrates the limits of the designed microarray when hybridizing
different strains of the same bacterial genus.
DNA from bovine tissue (negative control) (lung, liver, spleen, and kidney)
hybridized to two arrays did not show any significant binding with any of the bacterial
genes (1.41-2.98 with backgrounds of 2.42 and 1.53) (figure 17).
Almost all cross hybridization occurred within the probe sets designed from the
intergenic regions of S. typhimurium and L. monocytogenes. Therefore, these regions
were removed from data analysis. Furthermore, cross hybridization was limited to
random false positives that were not consistent in any of the repeated experiments. For
example, the S. typhimurium gene designated STM0417 showed a medium signal on one
of the P. multocida arrays at 6.23, but only produced signal values that ranged from 1.262.95 on the other seven P. multocida arrays. One major exception to this pattern was
found in the S. dublin array in which gDNA cross hybridized to a significant portion of
the S. typhimurium genes of which less than 1% had a higher signal than the highest S.
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dublin gene (23.44) and about 40% had a higher signal than the lowest S. dublin gene
signal considered positive (4.46).

Figure 10. Detection of P. multocida.

Figure 11. Detection of A. pyogenes.
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Figure 12. Detection of S. dublin.

Figure 13. Detection of M. haemolytica.
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Figure 14. Detection of H. somni.

Figure 15. Detection of E. coli.
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Figure 16. Hybridization Analysis of E. coli Probe Sets.

Figure 17. Detection of Bovine DNA extracted from lung, liver, kidney, and spleen.
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Detection of Pathogen-Spiked Tissue
DNA extracted from lung, liver, kidney, and spleen, all of which were spiked with
multiple bacterial species of confirmed identity (PCR), was hybridized individually to
four STYLMONOa520430F arrays. Field isolates of each pathogen were hybridized to
the arrays. The two exceptions were P. multocida (ATCC 12945), since we were unable
to obtain a field isolate, and E. coli (O157), because we have already shown that different
strains of E. coli do not hybridize to most of the E. coli probe sets. The signal value for
each pathogen was averaged across the arrays and multiple replicates. The overall
background for the arrays for comparison was 12.98. Positive signals were seen with P.
multocida (2062.08), H. somni (1527.33), M. haemolytica (2274.99), A. pyogenes
(152.78), S. dublin (1688.08), E. coli (2299.20) and S. typhimurium (2040.25) (figure 18,
values transformed with squareroot to bring the extreme value differences closer together
for easier comparison). With increased concentrations of DNA hybridized to the arrays,
some of the genes that were previously not producing signals, or were producing
relatively weak signals, were now showing stronger signals. We also observed signals
produced by the genes designated HS_16S_at, AP_smc_plo_ftsY_at, and SD_273_at,
where previously we saw no signal. However, even though these probe sets were now
showing hybridizing signals, they were still lower than their counterparts, further
confirming that different probe sets for the same pathogen had different detection limits.
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Figure 18. Detection of pathogens spiked into bovine tissue.
Discussion
Microarrays have the potential for detection of multiple bacterial species in cases
of mixed infections in a single assay. Here we report on the design and evaluation of a
simple DNA microarray used for the detection of pathogenic bacteria that commonly
afflict cattle. The prototype array was designed on an Affymetrix platform and contained
4686 probe sets representing 7 bacterial pathogens (P. multocida, H. somni, M.
haemolytica, and A. pyogenes, E. coli, S. typhimurium, and S. dublin) that commonly are
isolated from bovines. All of the genes selected for probe design were either selected
from BLAST comparisons or through a review of the literature. As such, each of the
bacterial species has a different number of genes represented on the array, from S.
typhimurium, represented by over 4500 genes, to H. somni and A. pyogenes, both with
only two genes represented.
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We have demonstrated the ability to detect P. multocida, A. pyogenes, S. dublin,
and S. typhimurium with as little as 250 ng of target DNA. We failed to detect M.
haemolytica, H. somni, and E. coli at 250 ng, but were able to detect them at 1 µg and
higher.
We also found that different probe sets for each pathogen had their own detection
limits. For example, in one of the P. multocida microarrays, the signal for each of the
positive probe sets ranged from 75.05 to 414.05. Also, some of the probe sets, such as
HS_16S_at, SD_273_at, and AP_smc_plo_ftsY_at, failed to produce signal at lower
concentrations even though fellow probe sets which target the same bacterial DNA
showed a strong signal. However, as increased target DNA concentrations were
hybridized, these seemingly “failed” probe sets were now successful in producing a
signal, though always lower than their counterparts. This data demonstrates that the
probe sets performed at different limits of detection.
Despite increases in hybridized target DNA, some probe sets, notably the 10 P.
multocida and 2 M. haemolytica genes, failed to ever produce a signal. PCR confirmed
that most of these exact sequences were not found in the genomes of the strains used in
this study. Exceptions include probe sets that targeted the 16S gene, indicating that a few
of the probe sets may not have been universally representative for the species of
bacterium they targeted.
We demonstrated that the probe sets were robust and able to target multiple
strains by successfully hybridizing and detecting at least two different strains for most of
the bacterial pathogens. Since two strains was the limit for most of the bacteria, further
tests using more strains are needed to confirm this. Exceptions were P. multocida (only
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one strain available) and E. coli. Since E. coli probe sets were designed from the O157
genome, we were not surprised when we saw strong signals when hybridized with O157
DNA. However, we were unable to see the same signal strength when we hybridized two
other pathogenic E. coli strains. Instead, only 4-5 genes sufficiently complimented the
probe sets to produce positive signals, and each strain produced a different hybridization
pattern.
Finally, we were able to show that we could detect bacterial DNA in tissue spiked
with mixed cultures. In experiments in which DNA, extracted from bovine lung, liver,
kidney, and spleen spiked with mixed cultures of pathogenic bacteria, was hybridized to
individual arrays, the arrays correctly detected and identified each bacterial pathogen. It
is interesting to note that the average detection signals for each of the spiked bacterial
pathogens were close at values of around 2000. However, A. pyogenes produced a value
of about 150 which is likely due to the fact that it was the only Gram + species in the
group, and may have experienced inefficient cell wall lysis. A change in the DNA
extraction protocol that would be more suited towards Gram + species would confirm
this.
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CHAPTER IV
SUMMARY
Microarray technology has a huge potential in veterinarian diagnostic
applications. Currently, there are a multitude of different diagnostic tests used to identify
specific pathogens. These tests can be collectively expensive and time consuming to
perform. Most of the tests require extensive handling of potentially zoonotic agents
requiring the need of BSL facilities, equipment, and proper training for safety reasons.
The diagnostics test designed here can detect and correctly identify the presence of
pathogenic bacteria using microarray technology by extracting bacterial DNA directly
from spiked tissue and hybridizing the mixed sample to our array. Though microarrays
can be individually expensive, an all-in-one diagnostic test is potentially less expensive
than running multiple tests that may be required for diagnosis of mixed infections.
In the designing of our microarrays, our primary goal was to design an array that
could correctly identify bovine pathogens from single and multiple infections. Our
secondary objective was to design an array that would not only be relatively inexpensive
to current standard microarray costs, but also be comparable to the costs of current
veterinarian diagnostic techniques, especially considering multiple tests would be
required to diagnose a multi-organ infections.
Our first array, the in-house platform, was designed and built as a cost-effective
microarray using in-house equipment and relatively cheap material that could identify
four respiratory pathogens (P. multocida, H. somni, M. haemolytica, A. pyogenes) that
commonly afflict cattle by targeting the 16S gene. The microarray array produced a
specific, easy-to-see, hybridization pattern that was unique to each of the four pathogens
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without the need for complicated analytical software. However, the biggest flaw in the
design was the need to first PCR-amplify the target DNA (16S gene) prior to
hybridization. Ultimately, with the technology available to us, we were unable to spot
the probes with sufficient concentration to allow detection of the target DNA without
prior amplification. One option to overcome this obstacle would be to design a set of
primers that would amplify the 16S gene of all the pathogens of interest in the same
reaction. However, we were more interested in showing that we could detect the
pathogen DNA from an infection without the need for amplification.
The second array was designed by partnering with Affymetrix, who had the
ability to create an array with a much higher probe concentration (as much as 1,000,000
probes/cm2). This custom array, which targeted multiple genes for seven bovine
pathogens (the previous four plus E. coli, S. typhimurium, S. dublin), was able to detect
all of the pathogens by hybridizing unamplified chromosomal DNA. Some of the
pathogens were detectable with as little as 250ng of DNA hybridized, while others
required at least 1ug. Also, we were able to successfully detect each pathogen from a
simulated multi-organ infection. The major drawback to the Affymetrix arrays is the cost
associated with each experiment. Indiviually, the GeneChips are more expensive than the
conventional in-house arrays. Also, specific and expensive equipment is also necessary
to process GeneChip arrays. Nevertheless, despite the added cost, the Affymetrix
platform is still be comparable to the cost of multiple diagnostics tests looking for
multiple infections.
Both microarray designs have advantages and disadvantages when compared with
each other. The Affymetrix arrays successfully detected each pathogen in simulated
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single and multiple infections without first requiring PCR-amplification of the target
genes. However, our in-house arrays were able to produce a visible hybridization pattern
without the need for software analysis, and the arrays were much cheaper, both in
constructing and processing the arrays, than their Affymetrix counterparts.

66

LITERATURE CITED
1 2004, Hemorrhagic Septicemia. In: Manual of standards for diagnostic tests and
vaccines for terrestrial animals, 5th ed., World Organization for Animal Health,
Paris.
2 2006, Pneumonic Pasteurellosis. In: The Merck veterinary manual, ed. Kahn CM, 9th
ed., Merck & Co., Inc., Whitehouse Station, NJ.
3 Angen O, Ahrens P, Tegtmeier C: 1998, Development of a PCR test for identification
of Haemophilus somnus in pure and mixed cultures. Vet Microbiol 63:39-48.
4 Annibali V, Di Giovanni S, Cannoni S, et al.: 2007, Gene expression profiles reveal
homeostatic dynamics during interferon-beta therapy in multiple sclerosis.
Autoimmunity 40:16-22.
5 Ausubel M, R. Brent, R.E. Kingston, D.D., et al.: 1988, Current protocols in
molecular biology.
6 Barone A, Beecher J, Bury P, et al.: 2001, Photolithographic synthesis of high-density
oligonucleotide probe arrays. Nucleosides Nucleotides & Nucleic Acids 20:525531.
7 Baugh L, Hill A, Brown E, Hunter C: 2001, Quantitative analysis of mRNA
amplification by in vitro transcription. Nucleic Acids Res 29:E29.
8 Booth S, Drebot M, Martin I, Ng L: 2003, Design of oligonucleotide arrays to detect
point mutations: molecular typing of antibiotic resistant strains of Neisseria
gonorrhoeae and hantavirus infected deer mice. Mol Cell Probes 17:77-84.
9 Borucki M, Krug M, Muraoka W, Call D: 2003, Discrimination among Listeria
monocytogenes isolates using a mixed genome DNA microarray. Vet Microbiol
92:351-362.
10 Buechler C, Schäffler A: 2007, Does global gene expression analysis in type 2
diabetes provide an opportunity to identify highly promising drug targets? Endocr
Metab Immune Disord Drug Targets 7:250-258.
11 Call D: 2005, Challenges and opportunities for pathogen detection using DNA
microarrays. Crit Rev Microbiol 31:91-99.
12 Carter RGR: 1998, Hemorrhagic Septicemia. In: Foreign Animal Diseases, pp. 265272. United States Animal Health Association, Richmond, VA.

67

13 Chen T: 2006, DNA microarrays--an armory for combating infectious diseases in the
new century. Infect Disord Drug Targets 6:263-279.
14 Christensen H, Bisgaard M, Larsen J, Olsen J: 2003, PCR-detection of Hemophilus
paragallinarum, Hemophilus somnus, Mannheimia (Pasteurella) hemolytica,
Mannheimia spp., Pasteurella trehalosi, and Pasteurella multocida. Methods Mol
Biol 216:257-274.
15 Clever L, LeGuyader Y: 1995, Infectious risks for health care workers. Annu Rev
Public Health 16:141-164.
16 Cobo F, Concha A: 2007, Application of microarray technology for microbial
diagnosis in stem cell cultures: a review. Cytotherapy 9:53-59.
17 Collet MG, Bath GF: 1994, Actinomyces pyogenes infections. In: Infectious
diseases of livestock: with special reference to Southern Africa, eds. Coetzer
JAW, Tustin RC, pp. 1406-1415. Oxford University Press, New York, NY.
18 Counts S, He B, Che S, et al.: 2007, Alpha7 nicotinic receptor up-regulation in
cholinergic basal forebrain neurons in Alzheimer disease. Arch Neurol 64:17711776.
19 Daudén E: 2007, [Pharmacogenetics II. Research molecular methods, bioinformatics
and ethical concerns]. Actas Dermosifiliogr 98:3-13.
20 de Reynies A, Geromin D, Cayuela J, et al.: 2006, Comparison of the latest
commercial short and long oligonucleotide microarray technologies. BMC
Genomics 7:51.
21 Ducray F, Honnorat J, Lachuer J: 2007, [DNA microarray technology: principles and
applications to the study of neurological disorders]. Rev Neurol (Paris) 163:409420.
22 Egervari K, Szollosi Z, Nemes Z: 2007, Tissue microarray technology in breast
cancer HER2 diagnostics. Pathol Res Pract 203:169-177.
23 Epstein C, Butow R: 2000, Microarray technology - enhanced versatility, persistent
challenge. Curr Opin Biotechnol 11:36-41.
24 Fadiel A, Naftolin F: 2003, Microarray applications and challenges: a vast array of
possibilities. Int Arch Biosci, pp. 1111-1121.
25 Feilotter H: 2004, Microarrays in veterinary diagnostics. Anim Health Res Rev
5:249-255.

68
26 Fisher M, Weiser G, Hunter D, Ward A: 1999, Use of a polymerase chain reaction
method to detect the leukotoxin gene lktA in biogroup and biovariant isolates of
Pasteurella haemolytica and P trehalosi. Am J Vet Res 60:1402-1406.
27 Freeman H, Noble M: 2005, Lack of evidence for Mycobacterium avium subspecies
paratuberculosis in Crohn's disease. Inflamm Bowel Dis 11:782-783.
28 Ganesan B, Chen D, Black R, et al.: 2007, Comparing microarray substrates for
optimal hybridization of genome-wide targets to oligomer probes. unpublished.
29 Gold V: 2006, The Gold Book: Compendium of chemical terminology. 2nd ed.,
International Union of Pure and Applied Chemistry., Research Triangle Park, NC.
30 Green A, DuTeau N, Miller M, et al.: 1999, Polymerase chain reaction techniques for
differentiating cytotoxic and noncytotoxic Pasteurella trehalosi from Rocky
Mountain bighorn sheep. Am J Vet Res 60:583-588.
31 Haferlach T, Bacher U, Kohlmann A, et al.: 2006, [Microarrays and gene expression
profiling for the diagnosis in leukemia. From research studies to routine
application]. Med Klin (Munich) 101:908-914.
32 Heller MJ: 2002, DNA microarray technology: Devices, systems, and applications.
Annu Rev Biomed Eng 4:129-153.
33 Hessner M, Meyer L, Tackes J, et al.: 2004, Immobilized probe and glass surface
chemistry as variables in microarray fabrication. BMC Genomics 5:53.
34 Hessner M, Xiang B, Jia S, et al.: 2006, Three-color cDNA microarrays with
prehybridization quality control yield gene expression data comparable to that of
commercial platforms. Physiol Genomics 25:166-178.
35 Hoerndli F, Pelech S, Papassotiropoulos A, Götz J: 2007, Abeta treatment and P301L
tau expression in an Alzheimer's disease tissue culture model act synergistically to
promote aberrant cell cycle re-entry. Eur J Neurosci 26:60-72.
36 Hoheisel J, Ross M, Zehetner G, Lehrach H: 1994, Relational genome analysis using
reference libraries and hybridisation fingerprinting. J Biotechnol 35:121-134.
37 Hood D, Deadman M, Cox A, et al.: 2004, Three genes, lgtF, lic2C and lpsA, have a
primary role in determining the pattern of oligosaccharide extension from the
inner core of Haemophilus influenzae LPS. Microbiology 150:2089-2097.
38 Hughes T, Mao M, Jones A, et al.: 2001, Expression profiling using microarrays
fabricated by an ink-jet oligonucleotide synthesizer. Nature Biotechnology
19:342-347.

69
39 Ishii M, Hashimoto S, Tsutsumi S, et al.: 2000, Direct comparison of GeneChip and
SAGE on the quantitative accuracy in transcript profiling analysis. Genomics
68:136-143.
40 Jayapal M, Melendez AJ: 2006, DNA microarray technology for target identification
and validation. Clinical and Experimental Pharmacology and Physiology 33:496503.
41 Jordan B: 2007, DNA microarrays in the clinic: how soon, how extensively?
Bioessays 29:699-705.
42 Jost B, Songer J, Billington S: 2002, Identification of a second Arcanobacterium
pyogenes neuraminidase and involvement of neuraminidase activity in host cell
adhesion. Infect Immun 70:1106-1112.
43 Kafatos F, Jones C, Efstratiadis A: 1979, Determination of nucleic acid sequence
homologies and relative concentrations by a dot hybridization procedure. Nucleic
Acids Res 7:1541-1552.
44 Kitching JP, Bishop GC: 1994, The Haemophilus somnus disease complex in cattle.
In: Infectious diseases of livestock: with special reference to Southern Africa, eds.
Coetzer JAW, Tustin RC, pp. 1135-1142. Oxford University Press, New York,
NY.
45 Korkola J, Estep A, Pejavar S, et al.: 2003, Optimizing stringency for expression
microarrays. Biotechniques 35:828-835.
46 Kuo W, Jenssen T, Butte A, et al.: 2002, Analysis of matched mRNA measurements
from two different microarray technologies. Bioinformatics 18:405-412.
47 Lennon G: 2000, High-throughput gene expression analysis for drug discovery. Drug
Discov Today 5:59-66.
48 Lequin R: 2005, Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay
(ELISA). Clin Chem 51:2415-2418.
49 Liu D, Lawrence M, Austin F: 2004, Specific PCR identification of Pasteurella
multocida based on putative transcriptional regulator genes. J Microbiol Methods
58:263-267.
50 Lockhart D, Dong H, Byrne M, et al.: 1996, Expression monitoring by hybridization
to high-density oligonucleotide arrays. Nature Biotechnology 14:1675-1680.
51 Loy A, Lehner A, Lee N, et al.: 2002, Oligonucleotide microarray for 16S rRNA
gene-based detection of all recognized lineages of sulfate-reducing prokaryotes in

70
the environment. Appl Environ Microbiol 68:5064-5081.
52 Loy A, Schulz C, Lücker S, et al.: 2005, 16S rRNA gene-based oligonucleotide
microarray for environmental monitoring of the betaproteobacterial order
"Rhodocyclales". Appl Environ Microbiol 71:1373-1386.
53 Luo L, Salunga R, Guo H, et al.: 1999, Gene expression profiles of laser-captured
adjacent neuronal subtypes. Nat Med 5:117-122.
54 Mahadevappa M, Warrington J: 1999, A high-density probe array sample preparation
method using 10- to 100-fold fewer cells. Nat Biotechnol 17:1134-1136.
55 Meyers-Wallen V: 2001, Relavence of the canine genome project to veterinarian
medical practice. In: Recent advances in small animal reproduction, eds.
Concannon PW, England GCW, Verstegen J, Linde-Forsberg C, International
Veterinary Information Service, Ithaca, NY.
56 Miflin J, Blackall P: 2001, Development of a 23S rRNA-based PCR assay for the
identification of Pasteurella multocida. Lett Appl Microbiol 33:216-221.
57 Mollet C, Drancourt M, Raoult D: 1997, rpoB sequence analysis as a novel basis for
bacterial identification. Mol Microbiol 26:1005-1011.
58 Nguyen D, Arpat A, Wang N, Carroll R: 2002, DNA microarray experiments:
biological and technological aspects. Biometrics 58:701-717.
59 Odenthal M, Koenig S, Farbrother P, et al.: 2007, Detection of opportunistic
infections by low-density microarrays: a diagnostic approach for granulomatous
lymphadenitis. Diagn Mol Pathol 16:18-26.
60 Ojha S, Kostrzynska M: 2008, Examination of animal and zoonotic pathogens using
microarrays. Vet Res 39:4.
61 Oberst Rd, Hays MP, Bohra LK, et al.: 2003, Detection of Escherichia coli O157:H7
in cattle feces using a polymerase chain reaction-based fluorogenic 5' nuclease
(TaqMan) detection assay after secondary enrichment. J Vet Diagn Invest 15:54352.
62 Pabon C, Modrusan Z, Ruvolo M, et al.: 2001, Optimized T7 amplification system
for microarray analysis. Biotechniques 31:874-879.
63 Panchuk-Voloshina N, Haugland R, Bishop-Stewart J, et al.: 1999, Alexa dyes, a
series of new fluorescent dyes that yield exceptionally bright, photostable
conjugates. J Histochem Cytochem 47:1179-1188.
64 Rogojina A, Orr W, Song B, Geisert E: 2003, Comparing the use of Affymetrix to

71
spotted oligonucleotide microarrays using two retinal pigment epithelium cell
lines. Molecular Vision 9:482-496.
65 Ryan K, Ray C: 2004, Sherris medical microbiology, 4th ed., eds. Ryan KJ, Ray CG,
pp. 247-249. McGraw-Hill, New York, NY.
66 Schena M, Shalon D, Davis R, Brown P: 1995, Quantitative Monitoring of GeneExpression Patterns with a Complementary-DNA Microarray. Science 270:467470.
67 Song S, Li B, Wang L, et al.: 2007, A cancer protein microarray platform using
antibody fragments and its clinical applications. Mol Biosyst 3:151-158.
68 Southern E: 2001, DNA microarrays. History and overview. Methods Mol Biol
170:1-15.
69 Tan P, Downey T, Spitznagel E, et al.: 2003, Evaluation of gene expression
measurements from commercial microarray platforms. Nucleic Acids Research
31:5676-5684.
70 Townsend K, Frost A, Lee C, et al.: 1998, Development of PCR assays for speciesand type-specific identification of Pasteurella multocida isolates. J Clin Microbiol
36:1096-1100.
71 Venter BJ, Myburgh JG, van der Walt ML: 1994, Bovine Salmonellosis. In:
Infectious diseases of livestock: with special reference to Southern Africa, eds.
Coetzer JAW, Tustin RC, pp. 1104-1112. Oxford University Press, New York,
NY.
72 Vernet G: 2007, Use of molecular assays for the diagnosis of influenza. Expert Rev
Anti Infect Ther 5:89-104.
73 Volokhov D, Rasooly A, Chumakov K, Chizhikov V: 2002, Identification of Listeria
species by microarray-based assay. J Clin Microbiol 40:4720-4728.
74 Wang E, Miller L, Ohnmacht G, et al.: 2000, High-fidelity mRNA amplification for
gene profiling. Nat Biotechnol 18:457-459.
75 Weimer, B, Desai P: 2008, personal communication, unpublished data.
76 Wills Q: 2007, SimuGen Ltd: Reliable, early prediction of drug toxicity with
toxicogenomics, human cell culture and computational models.
Pharmacogenomics 8:1081-1084.
77 Woo Y, Affourtit J, Daigle S, et al.: 2004, A comparison of cDNA, oligonucleotide,
and Affymetrix GeneChip gene expression microarray platforms. J Biomol Tech

72
15:276-284.
78 Xie Y, Chou L, Cutler A, Weimer B: 2004, DNA Macroarray profiling of
Lactococcus lactis subsp. lactis IL1403 gene expression during environmental
stresses. Appl Environ Microbiol 70:6738-6747.
79 Yuen T, Wurmbach E, Pfeffer R, et al.: 2002, Accuracy and calibration of
commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids
Research 30(10):e48.

73

APPENDIXES

74
APPENDIX A - Genes represented on the STYLMONOa520430F GeneChip
Probe Set Designation
Controls
AFFX-BioB-3_at
AFFX-BioB-5_at
AFFX-BioB-M_at
AFFX-BioC-3_at
AFFX-BioC-5_at
AFFX-BioDn-3_at
AFFX-BioDn-5_at
AFFX-CreX-3_at
AFFX-CreX-5_at
AFFX-r2-Ec-bioB-3_at
AFFX-r2-Ec-bioB-5_at
AFFX-r2-Ec-bioB-M_at
AFFX-r2-Ec-bioC-3_at
AFFX-r2-Ec-bioC-5_at
AFFX-r2-Ec-bioD-3_at
AFFX-r2-Ec-bioD-5_at
AFFX-r2-P1-cre-3_at
AFFX-r2-P1-cre-5_at
A. pyogenes
AP_16S_at
AP_smc_plo_ftsY_at

Gene Function
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
Affymetrix Hybridization Control
16S ribosomal RNA
chromosome segregation protein (smc) gene,
hypothetical protein, pyolysin (plo),
signal recognition particle receptor (ftsY)

H. somni
HS_16S_at
HS_rpoB_at

16S ribosomal RNA
rpoB gene

M. haemolytica
MH_16S_at
MH_lktA_at
MH_lpsA_at

16S ribosomal RNA
lktA leukotoxin
glycosyltransferase LpsA

P. multocida
PM_r01_at
PM_r02_at
All other probe sets

16S ribosomal RNA
23S ribosomal RNA
hypothetical proteins
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Probe Set Designation
S. dublin
All probe sets
E. coli
Z0146_RC_at
Z0213_x_at
Z0219_at
Z0334_RC_at
Z0967_at
Z1370_at
Z1385_RC_at
Z1797_at
Z1818_at
Z3622_at
Z3783_RC_at
All other probe sets

Gene Function
hypothetical proteins
yadC putative fimbrial protein
rrsH 16S ribosomal RNA
rrlH 23S ribosomal RNA
sidI putative capsid morphogenesis protein encoded
in CP-933I
putative protease encoded in prophage CP-933K
putative tail component encoded by cryptic
prophage CP-933M
putative secreted protein encoded by cryptic
prophage CP-933M
putative antirepressor of prophage CP-933N
putative antirepressor protein encoded by prophage
CP-933N
putative resolvase
putative dimethyl sulfoxide reductase subunit C
hypothetical proteins

S. typhimurium
All genes from chromosome and plasmid are represented
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APPENDIX B - R Code Used to Analyze Affymetix Arrays
library(affy) # For affy files
#memory.limit(size=4000) # Increase memory use
# Load in library files
library(makecdfenv)
#Choose Mac or Windows, not both.
#Mac
STYLMONOa520430F = make.cdf.env("STYLMONOa520430F.cdf")
#Windows
make.cdf.package("STYLMONOa520430F.cdf", species="Bovine_Pathogens")
# Read in .cel files from laptop
data = ReadAffy(celfile.path="//Users//Ryan//Desktop//RB1-30")
# RMA normalization and avg PM values for each chip
eset = expresso(data[1,30], bgcorrect.method = "rma", normalize.method = "constant",
pmcorrect.method = "pmonly", summary.method = "avgdiff")
# write the eset file to an excel spreadsheet
library(marray)
write.xls(eset, file = "Data.xls")
# Organize the data; create multiple files; 1 with positive probes; 1 with all background
noise; save them as .csv files
# Write subset probes to object
PM.sig.values = read.csv("C:\\Documents and Settings\\Ryan\\Desktop\\Data.pm.csv")
bg.sig.values = read.csv("C:\\Documents and Settings\\Ryan\\Desktop\\Data.bg.csv")

